1. Chini CCS, Tarragó MG, Chini EN. NAD and the aging process: Role in life, death and everything in between. Mol Cell Endocrinol 2017;455:62-74. 
  2. Covarrubias A, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 2021;22(2):119-141.
  3. Braidy N, Berg J, Clement J, et al. Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets . . . : rationale, biochemistry, pharmacokinetics, and outcomes. Antioxid Redox Signal 2019;30(2):251-294.
  4. Amjad S, Nisar S, Bhat AA, et al. Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol Metab 2021;49:101195.
  5. Guerville F, De Souto Barreto P, Ader I, et al. Revisiting the hallmarks of aging to identify markers of biological age. J Prev Alzheimers Dis 2020;7(1):56-64.
  6. López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell 2013;153(6):1194-217. 
  7. Fang EF, Kassahun H, Croteau DL. NAD+ replenishment improves lifespan and healthspan . . . via mitophagy and DNA repair. Cell Metab 2021;24(4):566-581. 
  8. Shammas MA. Telomeres, lifestyle . . . and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1):28-34.
  9. Kane AE, Sinclair DA. Sirtuins and NAD+ . . . . Circ Res 2018;123(7):868-885.
  10. Imai SI, Guarente L. It takes two to tango: NAD+ and sirtuins in aging/longevity control. NPJ Aging Mech Dis 2016;2:16017. 
  11. Amano H, Chaudhury A, Rodriguez-Aguayo C, et al. Telomere dysfunction induces sirtuin repression that drives telomere-dependent disease. Cell Metab 2019;29(6):1274-1290.e9. 
  12. van Deursen J. The role of senescent cells in ageing. Nature 2014;509(7501):439-446.
  13. Kirkland J, Tchkonia T. Cellular senescence: A translational perspective. EBioMedicine 2017;21:21-28.
  14. Gomes AP, Price NL, Ling AJ, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013;155(7):1624-1638.
  15. Zhang H, Ryu D, Wu Y, et al. NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 2016;352(6292):1436-1443. 
  16. Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, . . . Cell Metab 2011;14(4):528-536.
  17. Mills KF, Yoshida S, Stein LR, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab 2016;24(6):795-806. 
  18. Frederick DW, Loro E, Liu L, et al. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab 2016;24(2):269-282.
  19. de Picciotto NE, Gano LB, Johnson LC, et al. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell 2016;15(3):522-530.
  20. Gong B, Pan Y, Vempati P, et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression . . .. Neurobiol Aging 2013;34(6):1581-1588.